GlassScriptPhysician profile
Roger Hartl
NPI 1043236623
$96,679.61
in general payments reported to CMS, 2019-2025
26 companies · $6,904 in 2025
The $6,904 reported for 2025 was more than what 83% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,310 · 2020: $4,847 · 2021: $23K · 2022: $19K · 2023: $18K · 2024: $21K · 2025: $6,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $15K · Food and Beverage: $3,028 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,310 · Grant: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,567.50 |
| Travel and Lodging | $14,948.10 |
| Food and Beverage | $3,027.73 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,310.00 |
| Grant | $1,175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $34,242.87 | 2021-2025 | Spine & Trauma 3d Navigation, Teligen, Fibergraft Bg Morsels |
| Brainlab, INC. | $19,941.27 | 2019-2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Image Guided Surgical Device |
| Synthes Gmbh | $9,071.23 | 2019-2025 | |
| Carl Zeiss Meditec USA, INC. | $5,932.37 | 2022 | |
| Ethicon INC. | $4,501.50 | 2022-2024 | |
| Intrinsic Therapeutics | $4,250.00 | 2021 | |
| Depuy Synthes Sales INC. | $3,327.82 | 2019-2025 | Trialtis, Symphony, Synapse |
| Integrity Implants INC. | $2,976.61 | 2020-2022 | |
| Alphatec Spine, INC | $2,565.61 | 2020-2025 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $2,229.45 | 2019-2020 | |
| Nuvasive, INC. | $1,590.65 | 2019-2020 | |
| Ziehm-Orthoscan, INC. | $1,500.00 | 2020 | |
| Carl Zeiss Meditec Ag | $1,447.00 | 2021 | |
| Globus Medical, INC. | $1,174.96 | 2022-2024 | Adira |
| Atlas Spine, INC. | $500.00 | 2025 | Hijak |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $454.91 | 2022-2025 | Pliafx Flo |
| Viseon, INC. | $192.10 | 2022 | |
| 4web, INC. | $141.34 | 2024 | Spine Truss System |
| Orthofix Medical, INC. | $138.06 | 2023-2025 | Spinal-Stim, Spinal-Stim, Cervical-Stim |
| Spineart USA INC | $137.04 | 2022 | |
| Medtronic, INC. | $129.78 | 2022 | |
| Si-Bone, INC. | $100.47 | 2020 | |
| Depuy Synthes Products, INC. | $83.01 | 2022 | |
| Baxter Healthcare | $34.06 | 2020-2023 | Floseal |
| Biedermann Motech, INC. | $17.50 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,000,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Hartl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.